Macrogenics Stock (NASDAQ: MGNX) stock price, news, charts, stock research, profile.
|Vol / Avg.181.821K / 595.195K||Mkt Cap522.288M|
|Day Range8.370 - 8.850||52 Wk Range4.290 - 9.100|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-11-13||HC Wainwright & Co.||Robert Burns||Maintains||BuyBuy||Lowers||14.00||12.00|
|2023-08-10||HC Wainwright & Co.||Robert Burns||Reiterates||BuyBuy||Maintains||-||14.00|
|Ticker||Company||Chg %||Mkt Cap|
You can purchase shares of Macrogenics (NASDAQ: MGNX) through any online brokerage.
The latest price target for Macrogenics (NASDAQ: MGNX) was reported by Stifel on Monday, November 27, 2023. The analyst firm set a price target for 17.00 expecting MGNX to rise to within 12 months (a possible 101.90% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Macrogenics (NASDAQ: MGNX) is $8.42 last updated Today at December 11, 2023 at 4:38 PM UTC.
There is no dividend information for Macrogenics.
Macrogenics’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Macrogenics.
Macrogenics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.